Sana Biotechnology (SANA) Enterprise Value (2020 - 2026)
Sana Biotechnology (SANA) posted Enterprise Value of -$101.1 million for Q1 2026, down 32.96% sequentially from -$76.1 million in Q4 2025, and up 3.4% YoY from -$97.8 million in Q1 2025.
Sana Biotechnology (SANA) Enterprise Value (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Enterprise Value for 7 years, with the latest figure at -$101.1 million in Q1 2026.
- Quarterly Enterprise Value rose 3.4% year-over-year to -$101.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$101.1 million (up 3.4% YoY) and the FY2025 annual result came in at -$76.1 million, up 42.11% from the prior year.
- Enterprise Value slipped to -$101.1 million in Q1 2026 per SANA's latest filing, from -$76.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$72.7 million in Q2 2025 and troughed at -$512.4 million in Q1 2022.
- A 5-year average of -$186.1 million and a median of -$166.6 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value soared 71.93% in 2022, then sank 39.42% in 2024.
- Over 5 years, Enterprise Value stood at -$182.9 million in 2022, then climbed by 24.89% to -$137.3 million in 2023, then climbed by 4.33% to -$131.4 million in 2024, then soared by 42.11% to -$76.1 million in 2025, then plunged by 32.96% to -$101.1 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$101.1 million, -$76.1 million, and -$107.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | -160.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -160.49 Mn |
| Mar 31, 2026 | -101.14 Mn |
| Dec 31, 2025 | -76.07 Mn |
| Sep 30, 2025 | -107.55 Mn |
| Jun 30, 2025 | -72.67 Mn |
| Mar 31, 2025 | -104.70 Mn |
| Dec 31, 2024 | -131.40 Mn |
| Sep 30, 2024 | -130.83 Mn |
| Jun 30, 2024 | -251.64 Mn |
| Mar 31, 2024 | -180.89 Mn |
| Dec 31, 2023 | -137.35 Mn |
| Sep 30, 2023 | -172.28 Mn |
| Jun 30, 2023 | -180.49 Mn |
| Mar 31, 2023 | -166.56 Mn |
| Dec 31, 2022 | -182.87 Mn |
| Sep 30, 2022 | -169.44 Mn |
| Jun 30, 2022 | -484.80 Mn |
| Mar 31, 2022 | -512.38 Mn |
| Dec 31, 2021 | -551.00 Mn |
| Sep 30, 2021 | -603.71 Mn |